(Q68409930)
Statements
Successful combination immunotherapy for the generation in vivo of antitumor activity with anti-CD3, interleukin 2, and tumor necrosis factor alpha (English)
Yang SC
Fry KD
Grimm EA
1 February 1990
scientific article published on 01 February 1990
No description defined